Myositis Treatment Market Players:
- Baxter International, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eli Lilly and Company
- Novartis AG
- Sanofi-aventis Groupe
- Abbott Laboratories
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Siemens Healthcare GmbH
- Pfizer Inc.
- Becton, Dickinson and Company
- IBSRELA
- Indegene
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of myositis treatment is assessed at USD 753.47 million.
The global myositis treatment market size was valued at around USD 725.4 million in 2025 and is projected to grow at a CAGR of more than 4.3%, reaching USD 1.11 billion revenue by 2035.
By 2035, North America is poised to command a 37% share of the myositis treatment market during 2026-2035, supported by the escalating burden of musculoskeletal disorders.
Key players in the market include Baxter International, Inc., Eli Lilly and Company, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Johnson & Johnson Services, Inc., Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., Becton, Dickinson and Company, IBSRELA, Indegene.
